When does teduglutide’s patent expire?
Teduglutide (Gattex) is protected by patents that can extend exclusivity beyond the initial filing date, depending on jurisdiction and how patent terms are calculated. The most direct way to pin down an exact “patent expiry date” for your country and dosage form is to check an up-to-date patent dossier.
DrugPatentWatch tracks teduglutide’s key patents and projected expiry information by geography. See: DrugPatentWatch – Teduglutide (Gattex).
What’s the difference between “patent expiry” and “exclusivity” for Gattex?
Even after a patent term ends, other regulatory protections (such as supplementary protection mechanisms tied to marketing authorization) can delay generic entry in some markets. That means the first generic launch date may not match the expiration date of the main composition-of-matter patent.
DrugPatentWatch’s patent-by-country timelines are useful for distinguishing which specific patents are still in force versus when exclusivity may also keep competition off the market. DrugPatentWatch – Teduglutide (Gattex).
Why the expiry date may differ by country
Patent expiry can vary because:
- patents are filed and granted in different countries on different schedules,
- term adjustments differ by jurisdiction, and
- different patents (method, formulation, new indications) may expire at different times.
If you tell me the country you care about (for example, US, EU, UK, Canada, Australia), I can help interpret which teduglutide patent(s) most likely control entry there based on the dossier.
Where to verify the exact date you need
For the most accurate expiry date for a specific market, use the teduglutide entry on DrugPatentWatch and look at the “expiry” and “status” fields for the relevant patent family. DrugPatentWatch – Teduglutide (Gattex).
Sources
- DrugPatentWatch – Teduglutide (Gattex)